BioMS Medical Corp (TSX: MS) today announced
that it has entered into definitive agreements with select institutional
accredited investors to sell approximately 4.4 million units in a private
placement at a price of $3.41 per unit, for gross proceeds of approximately
$15 million. Each unit consists of one Class A common share of the Company and
one-half of one common share purchase with each whole warrant entitling the
holder to purchase one Class A common share at an exercise price of $4.00 per
share for a period of four years from the date of closing of the private
placement. The private placement is expected to close in the next several days
and is subject to approval of the Toronto Stock Exchange and other customary
closing conditions.
